Report Detail
Global In Vivo Pharmacology Market Growth (Status and Outlook) 2022-2028
- RnM4488413 |
- 30 August, 2022 |
- Global |
- 123 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
The global market for In Vivo Pharmacology is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC In Vivo Pharmacology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States In Vivo Pharmacology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe In Vivo Pharmacology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China In Vivo Pharmacology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key In Vivo Pharmacology players cover Charles River, The Jackson Laboratory, Syngene, Evotec and Pharmaron, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global In Vivo Pharmacology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global In Vivo Pharmacology market, with both quantitative and qualitative data, to help readers understand how the In Vivo Pharmacology market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the In Vivo Pharmacology market and forecasts the market size by Type (Animal Disease Models, Ex Vivo Pharmacology & Biomarkers and PD/PK), by Application (Ncology/Immuno-oncology, Metabolic Disorders, Inflammatory Diseases and CNS Diseases), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Animal Disease Models
Ex Vivo Pharmacology & Biomarkers
PD/PK
Others
Segmentation by application
Ncology/Immuno-oncology
Metabolic Disorders
Inflammatory Diseases
CNS Diseases
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Charles River
The Jackson Laboratory
Syngene
Evotec
Pharmaron
Aurigene Pharmaceutical
Jubilant Biosys
Labcorp
Inotiv
Takeda Pharmaceutical
EXUMA Biotech
Novartis
Be Biopharma
Alderley Oncology
Sygnature Discovery
GenScript ProBio
Zai Lab
Sinclair Research
Eli Lilly
Gubra
Chapter Introduction
Chapter 1: Scope of In Vivo Pharmacology, Research Methodology, etc.
Chapter 2: Executive Summary, global In Vivo Pharmacology market size and CAGR, In Vivo Pharmacology market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: In Vivo Pharmacology revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global In Vivo Pharmacology revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global In Vivo Pharmacology market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Charles River, The Jackson Laboratory, Syngene, Evotec, Pharmaron, Aurigene Pharmaceutical, Jubilant Biosys, Labcorp and Inotiv, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global In Vivo Pharmacology Market Size 2017-2028
- 2.1.2 In Vivo Pharmacology Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 In Vivo Pharmacology Segment by Type
- 2.2.1 Animal Disease Models
- 2.2.2 Ex Vivo Pharmacology & Biomarkers
- 2.2.3 PD/PK
- 2.2.4 Others
- 2.3 In Vivo Pharmacology Market Size by Type
- 2.3.1 In Vivo Pharmacology Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global In Vivo Pharmacology Market Size Market Share by Type (2017-2022)
- 2.4 In Vivo Pharmacology Segment by Application
- 2.4.1 Ncology/Immuno-oncology
- 2.4.2 Metabolic Disorders
- 2.4.3 Inflammatory Diseases
- 2.4.4 CNS Diseases
- 2.5 In Vivo Pharmacology Market Size by Application
- 2.5.1 In Vivo Pharmacology Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global In Vivo Pharmacology Market Size Market Share by Application (2017-2022)
3 In Vivo Pharmacology Market Size by Player
- 3.1 In Vivo Pharmacology Market Size Market Share by Players
- 3.1.1 Global In Vivo Pharmacology Revenue by Players (2020-2022)
- 3.1.2 Global In Vivo Pharmacology Revenue Market Share by Players (2020-2022)
- 3.2 Global In Vivo Pharmacology Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 In Vivo Pharmacology by Regions
- 4.1 In Vivo Pharmacology Market Size by Regions (2017-2022)
- 4.2 Americas In Vivo Pharmacology Market Size Growth (2017-2022)
- 4.3 APAC In Vivo Pharmacology Market Size Growth (2017-2022)
- 4.4 Europe In Vivo Pharmacology Market Size Growth (2017-2022)
- 4.5 Middle East & Africa In Vivo Pharmacology Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas In Vivo Pharmacology Market Size by Country (2017-2022)
- 5.2 Americas In Vivo Pharmacology Market Size by Type (2017-2022)
- 5.3 Americas In Vivo Pharmacology Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC In Vivo Pharmacology Market Size by Region (2017-2022)
- 6.2 APAC In Vivo Pharmacology Market Size by Type (2017-2022)
- 6.3 APAC In Vivo Pharmacology Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe In Vivo Pharmacology by Country (2017-2022)
- 7.2 Europe In Vivo Pharmacology Market Size by Type (2017-2022)
- 7.3 Europe In Vivo Pharmacology Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa In Vivo Pharmacology by Region (2017-2022)
- 8.2 Middle East & Africa In Vivo Pharmacology Market Size by Type (2017-2022)
- 8.3 Middle East & Africa In Vivo Pharmacology Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global In Vivo Pharmacology Market Forecast
- 10.1 Global In Vivo Pharmacology Forecast by Regions (2023-2028)
- 10.1.1 Global In Vivo Pharmacology Forecast by Regions (2023-2028)
- 10.1.2 Americas In Vivo Pharmacology Forecast
- 10.1.3 APAC In Vivo Pharmacology Forecast
- 10.1.4 Europe In Vivo Pharmacology Forecast
- 10.1.5 Middle East & Africa In Vivo Pharmacology Forecast
- 10.2 Americas In Vivo Pharmacology Forecast by Country (2023-2028)
- 10.2.1 United States In Vivo Pharmacology Market Forecast
- 10.2.2 Canada In Vivo Pharmacology Market Forecast
- 10.2.3 Mexico In Vivo Pharmacology Market Forecast
- 10.2.4 Brazil In Vivo Pharmacology Market Forecast
- 10.3 APAC In Vivo Pharmacology Forecast by Region (2023-2028)
- 10.3.1 China In Vivo Pharmacology Market Forecast
- 10.3.2 Japan In Vivo Pharmacology Market Forecast
- 10.3.3 Korea In Vivo Pharmacology Market Forecast
- 10.3.4 Southeast Asia In Vivo Pharmacology Market Forecast
- 10.3.5 India In Vivo Pharmacology Market Forecast
- 10.3.6 Australia In Vivo Pharmacology Market Forecast
- 10.4 Europe In Vivo Pharmacology Forecast by Country (2023-2028)
- 10.4.1 Germany In Vivo Pharmacology Market Forecast
- 10.4.2 France In Vivo Pharmacology Market Forecast
- 10.4.3 UK In Vivo Pharmacology Market Forecast
- 10.4.4 Italy In Vivo Pharmacology Market Forecast
- 10.4.5 Russia In Vivo Pharmacology Market Forecast
- 10.5 Middle East & Africa In Vivo Pharmacology Forecast by Region (2023-2028)
- 10.5.1 Egypt In Vivo Pharmacology Market Forecast
- 10.5.2 South Africa In Vivo Pharmacology Market Forecast
- 10.5.3 Israel In Vivo Pharmacology Market Forecast
- 10.5.4 Turkey In Vivo Pharmacology Market Forecast
- 10.5.5 GCC Countries In Vivo Pharmacology Market Forecast
- 10.6 Global In Vivo Pharmacology Forecast by Type (2023-2028)
- 10.7 Global In Vivo Pharmacology Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Charles River
- 11.1.1 Charles River Company Information
- 11.1.2 Charles River In Vivo Pharmacology Product Offered
- 11.1.3 Charles River In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Charles River Main Business Overview
- 11.1.5 Charles River Latest Developments
- 11.2 The Jackson Laboratory
- 11.2.1 The Jackson Laboratory Company Information
- 11.2.2 The Jackson Laboratory In Vivo Pharmacology Product Offered
- 11.2.3 The Jackson Laboratory In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 The Jackson Laboratory Main Business Overview
- 11.2.5 The Jackson Laboratory Latest Developments
- 11.3 Syngene
- 11.3.1 Syngene Company Information
- 11.3.2 Syngene In Vivo Pharmacology Product Offered
- 11.3.3 Syngene In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Syngene Main Business Overview
- 11.3.5 Syngene Latest Developments
- 11.4 Evotec
- 11.4.1 Evotec Company Information
- 11.4.2 Evotec In Vivo Pharmacology Product Offered
- 11.4.3 Evotec In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Evotec Main Business Overview
- 11.4.5 Evotec Latest Developments
- 11.5 Pharmaron
- 11.5.1 Pharmaron Company Information
- 11.5.2 Pharmaron In Vivo Pharmacology Product Offered
- 11.5.3 Pharmaron In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Pharmaron Main Business Overview
- 11.5.5 Pharmaron Latest Developments
- 11.6 Aurigene Pharmaceutical
- 11.6.1 Aurigene Pharmaceutical Company Information
- 11.6.2 Aurigene Pharmaceutical In Vivo Pharmacology Product Offered
- 11.6.3 Aurigene Pharmaceutical In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Aurigene Pharmaceutical Main Business Overview
- 11.6.5 Aurigene Pharmaceutical Latest Developments
- 11.7 Jubilant Biosys
- 11.7.1 Jubilant Biosys Company Information
- 11.7.2 Jubilant Biosys In Vivo Pharmacology Product Offered
- 11.7.3 Jubilant Biosys In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Jubilant Biosys Main Business Overview
- 11.7.5 Jubilant Biosys Latest Developments
- 11.8 Labcorp
- 11.8.1 Labcorp Company Information
- 11.8.2 Labcorp In Vivo Pharmacology Product Offered
- 11.8.3 Labcorp In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Labcorp Main Business Overview
- 11.8.5 Labcorp Latest Developments
- 11.9 Inotiv
- 11.9.1 Inotiv Company Information
- 11.9.2 Inotiv In Vivo Pharmacology Product Offered
- 11.9.3 Inotiv In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Inotiv Main Business Overview
- 11.9.5 Inotiv Latest Developments
- 11.10 Takeda Pharmaceutical
- 11.10.1 Takeda Pharmaceutical Company Information
- 11.10.2 Takeda Pharmaceutical In Vivo Pharmacology Product Offered
- 11.10.3 Takeda Pharmaceutical In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Takeda Pharmaceutical Main Business Overview
- 11.10.5 Takeda Pharmaceutical Latest Developments
- 11.11 EXUMA Biotech
- 11.11.1 EXUMA Biotech Company Information
- 11.11.2 EXUMA Biotech In Vivo Pharmacology Product Offered
- 11.11.3 EXUMA Biotech In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 EXUMA Biotech Main Business Overview
- 11.11.5 EXUMA Biotech Latest Developments
- 11.12 Novartis
- 11.12.1 Novartis Company Information
- 11.12.2 Novartis In Vivo Pharmacology Product Offered
- 11.12.3 Novartis In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Novartis Main Business Overview
- 11.12.5 Novartis Latest Developments
- 11.13 Be Biopharma
- 11.13.1 Be Biopharma Company Information
- 11.13.2 Be Biopharma In Vivo Pharmacology Product Offered
- 11.13.3 Be Biopharma In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 Be Biopharma Main Business Overview
- 11.13.5 Be Biopharma Latest Developments
- 11.14 Alderley Oncology
- 11.14.1 Alderley Oncology Company Information
- 11.14.2 Alderley Oncology In Vivo Pharmacology Product Offered
- 11.14.3 Alderley Oncology In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 Alderley Oncology Main Business Overview
- 11.14.5 Alderley Oncology Latest Developments
- 11.15 Sygnature Discovery
- 11.15.1 Sygnature Discovery Company Information
- 11.15.2 Sygnature Discovery In Vivo Pharmacology Product Offered
- 11.15.3 Sygnature Discovery In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 Sygnature Discovery Main Business Overview
- 11.15.5 Sygnature Discovery Latest Developments
- 11.16 GenScript ProBio
- 11.16.1 GenScript ProBio Company Information
- 11.16.2 GenScript ProBio In Vivo Pharmacology Product Offered
- 11.16.3 GenScript ProBio In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.16.4 GenScript ProBio Main Business Overview
- 11.16.5 GenScript ProBio Latest Developments
- 11.17 Zai Lab
- 11.17.1 Zai Lab Company Information
- 11.17.2 Zai Lab In Vivo Pharmacology Product Offered
- 11.17.3 Zai Lab In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.17.4 Zai Lab Main Business Overview
- 11.17.5 Zai Lab Latest Developments
- 11.18 Sinclair Research
- 11.18.1 Sinclair Research Company Information
- 11.18.2 Sinclair Research In Vivo Pharmacology Product Offered
- 11.18.3 Sinclair Research In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.18.4 Sinclair Research Main Business Overview
- 11.18.5 Sinclair Research Latest Developments
- 11.19 Eli Lilly
- 11.19.1 Eli Lilly Company Information
- 11.19.2 Eli Lilly In Vivo Pharmacology Product Offered
- 11.19.3 Eli Lilly In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.19.4 Eli Lilly Main Business Overview
- 11.19.5 Eli Lilly Latest Developments
- 11.20 Gubra
- 11.20.1 Gubra Company Information
- 11.20.2 Gubra In Vivo Pharmacology Product Offered
- 11.20.3 Gubra In Vivo Pharmacology Revenue, Gross Margin and Market Share (2020-2022)
- 11.20.4 Gubra Main Business Overview
- 11.20.5 Gubra Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on In Vivo Pharmacology. Industry analysis & Market Report on In Vivo Pharmacology is a syndicated market report, published as Global In Vivo Pharmacology Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of In Vivo Pharmacology market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
